Edwards Lifesciences (EW) PT Lifted to $130 at Piper Jaffray on 'Spectacular' Q3
Piper Jaffray analyst Brooks West reiterated an Overweight rating and boosted his price target on Edwards Lifesciences (NYSE: EW) to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
